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Goscinski and coworkers [1] investigated whether the
biological effects of exogenous endotoxin in a porcine model
could be neutralized by tobramycin, and whether tobramycin
or ceftazidime is able to modulate the inflammatory response.
There was no neutralization of the biological effects of
endotoxin in this porcine model. However, Goscinski and
colleagues suggest a possible anti-inflammatory effect by
both ceftazidime and tobramycin caused by a significantly
greater reduction in the IL-6 plasma level response to
endotoxin in comparison with the untreated group. No
significant difference in peak tumour necrosis factor (TNF)-α
or in rates of elimination of TNF-α between treatment groups
was seen.
The greater reduction in plasma IL-6 levels could be a marker
of a reduced inflammatory response. However, the lack of an
effect on the levels of TNF-α questions the conclusion drawn
regarding a reduction in the inflammatory response. IL-6 has
long been regarded as a proinflammatory cytokine induced
by lipopolysaccharide, along with TNF-α and IL-1. However,
although IL-6 is a potent inducer of the acute-phase
response, it has anti-inflammatory properties as well. Thus,
IL-6 attenuates the synthesis of IL-1 and TNF-α while having
little effect on the synthesis of anti-inflammatory cytokines
such as IL-10; it promotes the synthesis of IL-1 receptor
antagonist and soluble TNF receptor release in human
volunteers. The net results of these immunological effects
place IL-6 among the anti-inflammatory cytokine group [2]. It
was shown that IL-6, rather than playing a lethal role,
protected mice against death in a septic shock model [3].
Therefore, the authors’ suggestion that the reduction in IL-6
plasma levels in response to exogenous endotoxin by the
antibiotics ceftazidime and tobramycin may be beneficial in
the treatment of sepsis is questionable, because the
reduction in an anti-inflammatory cytokine may promote the
proinflammatory response, and hence adversely affect its
pathophysiology.
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